March 3, 2026

Chronic Kidney Disease and Risk of Diabetic Ketoacidosis in Type 1 Diabetes

Key Points

DKA risk remains unchanged with reduced eGFR levels in individuals with type 1 diabetes.
Specifically, eGFR values between 30 and 90 mL/min/1.73 m2 showed no association with DKA incidents.
This observational analysis highlights the need for additional research on SGLTi in type 1 diabetes management.
Future studies may clarify the kidney-protection benefits for selected individuals with type 1 diabetes.

Abstract

A reduced eGFR (between 30 and 90 mL/min/1.73 m2) alone was not associated with increased DKA risk. This finding supports further research into potential kidney-protection benefits of SGLTi for selected individuals with type 1 diabetes.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Abdulmohsen Bakhsh

Aman Saleemi

Dalton Budhram

University of Toronto

Journals

Diabetes Care

Actions

Institutions

University of Toronto

Wayne State University

University Health Network

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Chronic Kidney Disease and Risk of Diabetic Ketoacidosis in Type 1 Diabetes

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Also consider